Oncology Research Market Analysis and Reports | UK Conference Series

Market Analysis - Oncology Research 2017

Market Analysis Report:

Cancer is a disease in which abnormal cells divide uncontrollably and destroy body tissue.  There are more than 100 types of cancer, including breast cancer, skin cancer, lung cancer, colon cancer, prostate cancer, and lymphoma. Symptoms vary depending on the type. Cancer treatment may include chemotherapy, radiation, and/or surgery.

Cancer is a complex medical issue that requires a multidisciplinary approach. This approach is sweeping and ranges from well-being advancement to counteractive action and screening, diagnosis, treatment, restoration and palliative care.

Importance & Scope

Oncology Research 2017 will be the best platform for all the oncologists, haematologists, research scholars, students who are working in this field to exchange their knowledge related to Blood & Oncology Research. This international event is an effort to understand the underlying biological procedures which are amended to increase effectiveness, precision, survivability, and quality of life.

Specialists will clarify how another era of treatment alternatives gives patients new trust in the battle against cancer.

Geologically, the worldwide cancer treatment market is grouped into locales to be specific, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Middle East, Japan, and Africa. North America takes the biggest share of worldwide cancer growth treatment approximately 42% showcase took after by Europe approx. 26%. The worldwide oncology treatment market is required to develop in future because of expanding venture by multinational organizations in cancer look into.

           

Why London?

London is the capital and most crowded city of England and the United Kingdom with inhabitant populace of 7,500, making it the littlest city in England. Remaining on the River Thames, London has been a noteworthy settlement for two centuries.

London is a main worldwide city, with qualities of heritage, expressions, trade, training, diversion, fashion, fund, innovative work, social insurance, media, proficient administrations and tourism. In UK more than 90 Universities/schools, 200 pharmaceutical organizations, and more than 80 Associations and social orders are taking a shot at Cancer and other blood related scatters. Subsidizing awards by the legislature of china for research almost 200 million USD$ to colleges and 1.5 billion USD$ to the pharmaceutical and research establishments.

Conference Highlights:

·         Oncology

·         Cancer

·         Cancer Causes and Preventions

·         Cancer Diagnosis and Diagnostics

·         Cancer Treatment and Therapeutics

·         Cancer and Pharmacology

·         Biomarkers

·         Hematology

·         Haematologic Oncology

·         Breast Cancer

·         Blood Cancer

·         Blood Disorders

·         Immunology

·         Cancer Epidemiology

·         Clinical Trials and Case Report

·         Entrepreneurs Investment Meet

Why to attend..??

This exceptional universal meeting gives a stage to scientists and leaders in cancer research to display their most recent discoveries and find out about all the imperative advancements in disease investigate. Numerous researchers and widely renowned specialists will participate in the meeting. Over the course of the two day meeting, you will have the chance to both network and hear pioneers from the global scholastic and corporate cancer investigate groups.

Target Audience

Oncology Research 2017 welcomes the oncologists, hematologists, immunologists, pathologists, research scholars, doctors/clinicians, industrial professionals, student delegates and cancer associations & societies from biomedical and healthcare sectors to be a part of it.

         

Major Associations

In London

Cancer Research UK

Children with Cancer UK

United Kingdom Association of Cancer Registries

Children’s Cancer and Leukaemia Group

Leukaemia Cancer Society

Lymphoma Association

Leukaemia & Lymphoma Research

Myeloma UK

Leukaemia CARE

In USA

American Cancer Society (ACS)

Hematology/Oncology Pharmacy Association

Cancer Research Institute, USA

National Cancer Institute (USA)

American Society of Haematology

American Association for Cancer Research (AACR)

Association of International Cancer Research

National Cancer Institute

Lymphoma Research Foundation, USA

National Children’s Leukaemia Foundation, USA

International Myeloma Foundation

National Children's Leukemia Foundation

Childhood Leukemia Foundation

Cancer and Leukemia Group B

International Agency for Research on Cancer (IARC)

Union for International Cancer Control (UICC)

Prevent Cancer Foundation

American Childhood Cancer Organisation

Worldwide

Union for International Cancer Control

International Fanconi Anemia Registry (IFAR)

Armenian Association of Hematology & Oncology

Cancer Association of South Africa

Canadian Cancer Sociey

Society for Paediatric Oncology & Hematology

Chinese Society of Clinical Oncology

Cancer Research UK

Indian Association of blood cancer & Allied Diseases

The Leukaemia and Lymphoma Society of Canada

Leukaemia Cancer Society

Leukaemia & Blood Cancer New Zealand

Korean Cancer Association

Fanconi Anaemia Australia

Leukaemia Foundation of Australia

Indian Cancer Society

Brazilian Lymphoma & Leukaemia Association

Chronic Myelogenous Leukaemia Society of Canada

Children’s Cancer and Leukaemia Group

German Cancer Society

Lymphoma Foundation Canada

Cancer Society of Finland

France Lymphoma Hope

Leukaemia &Blood Cancer, New Zealand

Medical Oncology Group of Australia

Australian & New Zealand Children’s Hematology/Oncology Group

Childhood Cancer Research Group, UK

National Cancer Institute of Argentina

Cancer Society Nepal

Top Universities

In London

University of Oxford

University of Cambridge

King's College London

UCL Medical School

Queen Mary, University of London

Imperial College, London

Institute on Cancer Research

St. George’s, University of London

The University of Sheffield

In USA

Harvard University

Stanford University

Cambridge University

Mayo Medical School, US

John Hopkins University

Yale University

University of Colorado

St. George’s University

Emory University

University of California

University of Maryland, Baltimore

North-western University, IIlinois

University of Texas

Massachusetts Institute of Technology (MIT)

Carnegie Mellon University, United States of America

University of Pennsylvania, Philadelphia

Indiana University School of Medicine, Melvin and Bren Simon Cancer Center

University of Rochester, New York

Cornell University, United States of America

Baylor COLLEGE of medicine US

Columbia University, New York

University of Iowa

Princeton University, US

University of Minnesota Medical Center

University of Auckland

University of Michigan

University of Melbourne

Ohio State University, Columbus

Rockefeller University, US

Worldwide

University of Chicago, Chicago

University of Toronto, Canada

Washington University in St. Louis

Thomas Jefferson University

National University of Singapore (NUS), Singapore

Indianapolis University “La Sapienza” of Rome, Rome, Italy

University of Wisconsin, Madison-

University of Tokoyo, Japan

Guangxi Medical University, Nanning, China

University of Lyon, France

University Of Leeds

University Of Queensland,Australia

University of Arizona Cancer Center

University of Utah

Georgetown University Medical Center

 University of Southampton

University of Pittsburgh

 McMaster University

University Of Florida

Vanderbilt University School of Medicine

Wayne State University School of Medicine

University of Alberta

University Of British Columbia

University Of Leicester

 University Of Chester

University of Kentucky

University of north Durham

 University Of Surrey

 University Of Edinburgh

 University of Glasgow

 University Of Bordeaux,France

Oregon Health and Science University

 Knight Cancer Institute

Loyola University Chicago

University oF Louisville

 University of Toledo

Rutgers University

University Of Calgary

University Of Witaterstrand

University Of Western Sydney, Australia

University of Melbourne

University Of South Australia

University Of New South Wales

Monash University, Australia

University of Milan, Italy

Kyoto University, Japan

The University of Auckland, NZ

University Of Zurich

National Taiwan University

The University of Manchester, UK

Ichan School of medicine, Mount Sinai

Pondicherry University, India

University of phoenix

Griffith University

University Of Exeter

Crimea State Medical University,Ukriane

 Heidelberg University

 Hackensack University Medical Center

 Kyoto University, Taiwan

 Osaka University, Japan

 Kursk State Medical University, Russia

Companies

Roche group is one of the main suppliers of cancer growth treatment drugs. A portion of the key players in cancer treatment market are Novartis Pharmaceuticals, Celgene Corporation, Merck & Co., Bristol-Myers Squibb Company, AbbVie Inc., Johnson and Johnson Pvt. Ltd., Amgen Inc., Teva pharmaceutical Industries Ltd., Bayer AG, Pfizer Inc., Takeda Pharmaceutical Co. Ltd.

Market Analysis report

The market of cancer is communicated to show unfaltering development rate amid the estimate time frame from 2015 – 2020. This development is driven by main considerations, for example, rising predominance of different infections and broad R&D practices are progressing over the globe to bring new and more successful medications and plans in the market.

Progression in innovation customized pharmaceutical, financially savvy treatment methods are couple of different components anticipated to keep up the development of worldwide cancer treatment showcase. However, unique nature of blood diseases and expanding stringency in the administrative prerequisites are a portion of the real restrictions constraining the development of worldwide tumor treatment showcase.

The worldwide market for Oncology medications was assessed to be $25.8 billion in 2015. By 2017, the market is relied upon to reach $42.5 billion, developing at a CAGR of 12% in the vicinity of 2015 and 2017. The aggregate worldwide market for oncology issue medications and diagnostics in 2015 was assessed at almost $82.3 billion. By 2017, the market is relied upon to reach $99.3 billion, developing at a compound yearly development rate (CAGR) of 7.2% in the vicinity of 2015 and 2017. The worldwide cancer issue advertise section is evaluated at $53.3 billion in 2015 and is relied upon to reach about $76.7 billion by 2017. The real purpose behind the low development rate is the normal decrease in the yearly cost of treating cancer issue and the patent lapses of Lovenox, Plavix, Procrit/Epogen, Aranesp, and Neulasta. In 2010, every one of these medications together achieved income of $32 billion into the worldwide blood issue advertise.

 

Conferenceseries LLC invites all the participants across the globe to attend CME Accredited 
 "8th International Conference on Blood and Oncology Research” slated on June 26-27, 2017 London, UK.

Theme: We share something that kills Cancer

Dates: June 26-27, 2017

Venue: London, UK

Accredatation: CME

Target Audience

  • Oncologists
  • Heamotologists
  • Radiologists
  • Pathologist
  • Immunologist
  • Clinical Researchers
  • Nurses 
  • Cancer  Researchers
  • Scientists
  • Young research
  • Student
  • Cancer Associations and Societies
  • Business Entrepreneurs
  • Training Institutes
  • Software developing companies
  • Manufacturing Medical Devices Companies
  • Data Management Companies
  • Pharmaceutical Companies
  • Diagnostics Companies